Differential expression of PITX1 has been reported in many malignant tumors and is associated with the survival prognosis of patients in several types of cancers, such as lung adenocarcinoma [12], osteosarcoma [8], esophageal squamous carcinoma [13], and head and neck squamous cell carcinoma [14]. Here, PITX1 is linked to cancer.